Aescuvest, founded in 2014 and based in Frankfurt, Germany, is a venture capital firm focused on the healthcare sector. Its mission is to facilitate impactful investments in medical innovations that enhance healthcare delivery models, products, and services. Aescuvest allows investors to create personalized portfolios of healthcare start-ups aligned with their investment preferences. Collaborating with EIT Health and leveraging a broad network of partnerships across Europe, Aescuvest sources and evaluates promising healthcare investment opportunities. The firm structures financing rounds and enables various investors, including Business Angels and Family Offices, to engage in direct investments via Special Purpose Vehicle (SPV) structures. Aescuvest's Investment Committee, composed of its investment team and an Advisory Board with extensive healthcare industry experience, employs a rigorous pre-screening and due diligence process to identify viable start-ups. The management team also invests their own capital in each company before introducing them to the wider investor base, ensuring alignment of interests. This combination of innovative equity capital solutions and healthcare expertise offers Aescuvest's portfolio companies a unique platform to accelerate commercialization and navigate market access challenges.
XO Life operates an online platform focused on digital patient monitoring and engagement. The platform is designed to enhance patient education and support by offering real-world insights into patient preferences and treatment outcomes. It facilitates communication between patients and pharmaceutical companies, allowing for the exchange of feedback and information that improves adherence to treatments. By providing services such as patient companionship and insights into various drugs and diseases, XO Life aims to foster better relationships between patients and healthcare providers, ultimately contributing to improved patient outcomes and loyalty.
Neteera specializes in remote contactless sensing technology that enables continuous and non-invasive monitoring of human vital signs. Utilizing a micro-radar on chip and proprietary algorithms, the company detects microscopic skin motions even through clothing and furniture. This high-frequency sensing technology allows for the monitoring of various physiological parameters, including heart and respiration rates, heart rate variability, inhale-exhale ratio, and tidal volume. By focusing on seamless and safe biometric identification, Neteera provides a cost-effective solution for clients seeking to implement continuous health monitoring without the need for physical contact.
Neteera specializes in remote contactless sensing technology that enables continuous and non-invasive monitoring of human vital signs. Utilizing a micro-radar on chip and proprietary algorithms, the company detects microscopic skin motions even through clothing and furniture. This high-frequency sensing technology allows for the monitoring of various physiological parameters, including heart and respiration rates, heart rate variability, inhale-exhale ratio, and tidal volume. By focusing on seamless and safe biometric identification, Neteera provides a cost-effective solution for clients seeking to implement continuous health monitoring without the need for physical contact.
Piur Imaging GmbH, founded in 2014 and headquartered in Vienna, Austria, specializes in developing innovative tomographic ultrasound technology that transforms standard ultrasound systems into advanced 3D imaging devices. Their flagship product, the PIUR tomographic ultrasound (tUS), enhances clinical applications such as endovascular aneurysm repair (EVAR) surveillance, offering superior endoleak detection and classification compared to traditional CT angiography. Additionally, the technology provides high-resolution carotid angiography for better planning of endarterectomy or stent placement and enables rapid 3D vascular mapping of superficial arteries and veins for bypass or arteriovenous fistula planning. Focused on making vascular imaging both affordable and safe, Piur's solutions leverage AI algorithms for efficient diagnostics, particularly in thyroid imaging, allowing for quick and objective analysis of thyroid nodules.
XO Life operates an online platform focused on digital patient monitoring and engagement. The platform is designed to enhance patient education and support by offering real-world insights into patient preferences and treatment outcomes. It facilitates communication between patients and pharmaceutical companies, allowing for the exchange of feedback and information that improves adherence to treatments. By providing services such as patient companionship and insights into various drugs and diseases, XO Life aims to foster better relationships between patients and healthcare providers, ultimately contributing to improved patient outcomes and loyalty.
Medikura provides communication infrastructure enabling multidirectional drug-related information exchange between patients, medical experts, and pharma to improve drug effectiveness and safety setting.
Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company is known for its flagship product, munevo DRIVE, a Smartglass application that enables users to control electric wheelchairs through head movements, translating these movements into digital signals for hands-free operation. This technology provides users with greater independence and the ability to navigate both indoor and outdoor environments. In addition to the Smartglass application, Munevo also offers various adaptors and accessories to complement its solutions, further supporting the mobility needs of its users.
Emperra E-Health Technologies, founded in 2008 and located in Potsdam, Germany, specializes in developing tele-medical products for diabetes management. The company focuses on creating systems that facilitate the tracking, monitoring, and transmission of diagnostic and therapeutic data for diabetic patients. Emperra's innovative solutions include a Bluetooth-enabled insulin pen and a wireless blood glucose meter, which provide healthcare professionals with essential therapy information. These products enable doctors and nurses to effectively monitor patients' insulin doses, blood sugar levels, and carbohydrate intake, improving overall diabetes care.
Lipozyt Marker provides oral anti-diabetic therapy. They offer a test kit that conducts mRNA analysis of the subcutaneous fatty tissue in combination with classic blood tests to determine individual causes of diabetes.
BOCAhealth is a patented portable device (connected to an app) that is able to measure and keep track of the hydration status of a user without the need for medical personnel.
Surge-On Medical specializes in the development of innovative surgical instruments designed for minimally invasive procedures, particularly in arthroscopy and laparoscopy. The company offers steerable, detachable, and cleanable instruments that enhance surgical reachability and facilitate easier cleaning, ultimately improving the efficiency of surgical procedures. By providing surgeons with better access to challenging surgical areas, Surge-On Medical aims to advance surgical techniques and patient outcomes.
Medivid is a cooling therapy for tendons, ligaments, muscles, and joints. Their therapy set contains the ingredients needed to start with consistent cooling therapy for symptoms.
Adiuvad offers services for both in-clinic and home rehabilitation as it includes gait training. They provide a therapy device that allows the patient to get into the device from a wheelchair or bed and do walking exercises and interrupt the exercise.
VisionHealth GmbH is a healthcare technology company based in Munich, Germany, founded in 2017. It specializes in creating software solutions for patients with various respiratory diseases, particularly those reliant on inhalers for conditions such as asthma and COPD. Its primary product, Kata, is a digital healthcare assistant that utilizes artificial intelligence and machine learning to improve inhalation therapy. The application facilitates effective inhaler use by providing training and support, helping patients avoid shortness of breath and reduce the need for hospital visits. By enhancing the management of chronic lung conditions, VisionHealth aims to lower therapy costs and improve the overall quality of life for patients.
Check-Up Scout provides health prevention and evidence-based medicine and self-learning processes. Additionally, they also provide health care more individuals and health care software applications.
MediTip-Medical MTM GmbH specializes in the supply of disposable medical instruments and treatment units for healthcare providers, including doctors and hospitals. The company offers a variety of sterile, single-use products such as clamps, dental sets, needle holders, tweezers, spatulas, and spoons. All products are manufactured under stringent quality management standards tailored for medical devices, ensuring they meet the necessary safety and efficacy requirements. By providing these disposable items, MediTip-Medical MTM helps healthcare facilities minimize the risk of cross-contamination and infections, thereby enhancing patient safety and care efficiency.
MOIO GmbH, founded in 2017 and headquartered in Fürth, Germany, develops and distributes innovative digital health solutions. Its flagship product, the moio.care system, features a sensor-based patch designed for both in-patient and out-patient care. This smart care patch can monitor user movement, trigger alarms when individuals leave defined areas, and detect falls to alert caregivers. The device can be worn comfortably on the skin using options like adhesive strips or a soft ribbon around the hips. By leveraging partnerships in research and industry, MOIO GmbH aims to continuously enhance and expand its offerings in the healthcare market, ultimately improving care for individuals in need.
Rodos BioTarget (RBT) is a biopharmaceutical company developing a targeted drug delivery platform. RBT’s patented TargoSphere® technology enables carrying a broad range of active agents selectively into the center of the immune response - i.e., directly into antigen-presenting cells. RBT currently applies its TargoSphere® technology successfully in various models of infectious diseases caused by viruses like HCV/ Hepatitis C and HIV/ AIDS and by bacteria like in Tuberculosis, Legionellosis, and MRSA. Yet, any disorder that goes along with either overshooting or insufficient immunity caused by antigen-presenting cells - like chronic inflammations, cancers, allergies, and autoimmune diseases - may be addressed by RBT’s TargoSphere® technology.
Epinamics specializes in pharmaceutical research and development, focusing on innovative drug delivery technologies. The company has developed a polymer-based, sprayable, and film-forming therapeutic pump designed for dermal and transdermal applications. This technology allows for the effective delivery of medicinal drugs in high concentrations and low volumes, enhancing patient experience and outcomes. Epinamics' expertise enables it to expedite the process of bringing medical products to market, whether by utilizing existing technologies or by assisting in the development of new pharmaceutical ingredients. This commitment to innovation positions Epinamics as a valuable player in the pharmaceutical industry, particularly in the realm of advanced drug delivery systems.
ImmunoLogik is a biotechnology company that specializes in the discovery, development, and commercialization of antiviral drugs aimed at treating viral infections, including those caused by SARS-CoV-2. The company provides a broad-spectrum antiviral medication designed for patients infected with COVID-19, as well as therapies for various immune system disorders. ImmunoLogik is particularly focused on developing innovative treatments for HIV-positive patients, thereby enhancing the available options for healthcare professionals in managing these infections. Through its research and development efforts, ImmunoLogik aims to address both current and future challenges posed by viral diseases.
nice!innovations
Equity Crowdfunding in 2015
nice! innovations GmbH is developing a new type of external fixator system - the so-called "snakeFX".
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.